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Preventing SARS-CoV-2 transmission and protecting people from 
COVID-19 is the most significant public health challenge faced in 
recent years. COVID-19 outbreaks are occurring in workplaces and 
evidence is needed to support effective strategies to prevent and 
control these outbreaks. Investigations into these outbreaks are 
routinely undertaken by public health bodies and regulators in the 
United Kingdom (UK); however, such investigations are typically 
disparate in nature with a lack of consistency across all investigations, 
preventing meaningful analysis of the data collected. 
 
The COVID-OUT (COVID-19 Outbreak investigation to Understand 
Transmission) study aims to collect a consistent set of data in a 
systematic way from workplaces that are experiencing outbreaks, to 
understand SARS-CoV-2 transmission risk factors, transmission routes, 
and the role they play in the COVID-19 outbreaks. 
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Suitable outbreak sites are identified from public health bodies. 
Following employer consent to participate, the study will recruit 
workers from workplaces where there are active outbreaks. The study 
will utilise data already collected as part of routine public health 
outbreak investigations and collect additional data through a 
comprehensive questionnaire, viral and serologic testing of workers, 
surface sampling, viral genome sequencing, and an environmental 
assessment of building plans, ventilation and current control 
measures. At each site, a detailed investigation will be carried out to 
evaluate transmission routes. A case-control approach will be used to 
compare workers who have and have not had SARS-CoV-2 infections 
during the outbreak period to assess transmission risk factors. Data 
from different outbreaks will be combined for pooled analyses to 
identify common risk factors, as well as factors that differ between 
outbreaks. 
 
The COVID-OUT study can contribute to a better understanding of 
why COVID-19 outbreaks associated with workplaces occur and how 
to prevent these outbreaks from happening in the future.
Keywords 
COVID-19, SARS-CoV-2, outbreak, investigation, transmission, 
environment, workplace, epidemiology
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Introduction
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
is a highly transmissible virus that has caused a pandemic 
of the “coronavirus disease 2019” (COVID-19)1. The rela-
tive contributions of different routes of transmission are not 
well understood, including droplets and potential roles of 
close-range airborne routes, long-range inhalation of aero-
sols, and contact with contaminated surfaces2. Uncertainties 
remain on what extent environmental factors, such as tempera-
ture, humidity and ventilation, can alter the dynamics of trans-
mission in a range of indoor settings3,4. In October 2020, the 
United Kingdom (UK) established the COVID-19 National 
Core Studies (NCS), including a programme on Transmission 
and Environment, which is also known as “PROTECT”: The 
Partnership for Research into Occupational, Transport and 
Environmental Covid NCS. This programme aims to provide 
critical evidence to prevent or more effectively control 
SARS-CoV-2 transmission in all potential exposure scenarios 
(e.g. in workplaces). The COVID-OUT (COVID-19 Outbreak 
investigation to Understand Transmission) study is part of 
Theme 1 of this wider programme and will specific focus on 
investigating COVID-19 outbreaks in the workplace5. This 
study is coordinated by the Health and Safety Executive 
(HSE) in collaboration with Public Health England (PHE), the 
University of Manchester (UoM) and the London School of 
Hygiene & Tropical Medicine (LSHTM).
Since the start of the pandemic, COVID-19 outbreaks have 
been reported in congregate settings, such as workplaces, 
schools, care homes, and hospitals. A PHE surveillance report of 
COVID-19 in England reported 645 of the 4,145 confirmed 
or suspected outbreaks of acute respiratory infections were 
linked to a workplace setting over a 4-week period, between 
November and December 20206. A survey conducted by the 
European Centre for Disease Prevention and Control (ECDC) 
reported a total of 1,377 COVID-19 clusters in workplace 
settings across 13 EU/EEA countries and the UK between 
March and July 2020, which included 153 clusters in food 
packing and processing plants, 77 in non-food manufactur-
ing facilities and 65 in office settings7. Factors associated with 
increased risks of viral transmission and outbreak occurrence 
in a workplace are a priori likely to be complex and could 
be related to worker’s underlying health conditions; socio-
economic position and living conditions (e.g. household 
crowding); preventative behaviours (e.g. adherence to physical 
distancing interventions, hand washing and wearing a face 
covering); nature of contacts and social interactions at work, 
outside of work or on the way to/from work; the physical 
workplace environment, as well as the types and effectiveness 
of control measures implemented.
In the UK, investigations into COVID-19 outbreaks in work-
places are routinely undertaken by public health bodies 
(e.g. PHE and local authority public health departments) and 
regulators (e.g. HSE). Due to the diversity of situations that 
occur, and the bespoke approaches needed for these, there is 
inconsistency in the types and quality of data collected across 
these investigations, limiting the potential for meaningful 
joint analyses of and comparisons between outbreaks at present. 
The COVID-OUT study will apply a standardised approach 
to workplace outbreak investigations in order to generate 
optimal data for research.
The COVID-OUT study aims to understand SARS-CoV-2 
transmission risk factors, transmission routes, and their rela-
tive importance in COVID-19 outbreaks associated with 
workplaces. The primary objectives are: 1) to understand the 
potential risk factors for SARS-CoV-2 transmission associ-
ated with workers and work activities in workplace outbreaks; 
2) to identify key characteristics associated with the workplace 
settings that could enhance viral transmission, and their rela-
tive importance in workplace outbreaks; and 3) to understand 
the potential transmission routes of SARS-CoV-2 in a work-
place outbreak. The secondary objectives are: a) to estimate the 
number and proportion of SARS-CoV-2 infections in a work-
place outbreak; b) to estimate the number and proportion of 
asymptomatic infections in a workplace outbreak; c) to evaluate 
the contribution of asymptomatic and pre-symptomatic transmis-
sions to workplace outbreaks; d) to assess SARS-CoV-2 envi-
ronmental contamination and its links to transmission within 
a workplace outbreak; and e) to generate evidence on the effec-
tiveness of a range of control measures currently implemented 
in preventing COVID-19 transmission in workplaces.
The study is designed to achieve its aims and objectives 
through analysing data collected in real-time during ongoing 
COVID-19 outbreaks in workplaces in the UK.
Protocol
Study design overview
At each site, a detailed outbreak investigation will be conducted 
to evaluate potential transmission routes and a case-control 
approach will be used to assess transmission risk factors by 
comparing workers who have and have not had SARS-CoV-2 
infections during the outbreak period.
Comprehensive data on workers and their work environments 
will be collected via questionnaires, biological sampling of work-
ers (e.g. viral testing and genomic sequencing, and antibody 
testing) and environmental assessment and sampling (Figure 1).
A general data framework (Table 1), together with data collec-
tion tools, has been developed. These will be applied consist-
ently to collect data from outbreak investigations in a range of 
workplace settings, so that data from multiple outbreaks can 
be pooled together to increase statistical power.
The COVID-OUT study has been designed using a set of 
relevant World Health Organization (WHO) COVID-19 Early 
Investigation Protocols, including the protocol for the assess-
ment of risk factors for COVID-19 in health workers8, the 
investigation protocol for the first few cases and contacts9, the 
seroepidemiological investigation protocol10 and the protocol 
for surface sampling11. These protocols have been combined 
and adapted for the investigation of workplace outbreaks 
in the UK.
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Figure 1. The COVID-OUT study activity flow chart.
Table 1. A general data collection framework for COVID-19 outbreak investigation.





COVID-19-related symptoms, tests and vaccination, employment contract, financial impact of self-isolation, work activities, nature 
of interactions within work and outside of work, hand hygiene, face covering, method of travel to work, living conditions and recent 
history of travel.
2. Data at the workplace environmental level
   ○   Influencing factors of viral exposure and transmission will be measured, including building layout, ventilation, temperature, 
humidity, air movement and noise level through environmental assessment. These will provide opportunities to link laboratory-
confirmed cases with potential sources of infection.
   ○   The work environment will be sampled to measure the quantity of viral RNA from high-risk environments, in particular those linked 
to work areas from recent positive cases and communal areas.
   ○   Any environmental samples producing high levels of viral RNA will be further assessed by whole genome sequencing and viral 
isolation. 
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A general data framework and data collection tools
A general data framework, based on knowledge acquired from 
previous responses to global emerging pathogens12,13, and 
considering individual, environmental, and population level 
data, has been developed for this study to assist in the conduct 
of a comprehensive investigation of outbreaks in workplaces 
(Table 1).
In accordance with the general data framework, a set of core 
data collection tools have been developed that can be applied 
consistently to the study across multiple outbreak sites. These 
are described as follows:
Questionnaire14. A two-part, online, self-administered ques-
tionnaire was developed based on the European OMEGA-NET 
COVID-19 Questionnaires15 and a PHE outbreak investigation 
checklist. In consultation with National Core Study programme 
scientists and HSE inspectors, additional questions were 
created and piloted to assess close contacts, control measures, 
talking loudly due to high noise level, ventilation, history of 
COVID-19 testing, and vaccination status. The question-
naire includes: 1) a baseline questionnaire to collect data 
from study participants at the beginning of the study, and 2) a 
follow-up questionnaire before each subsequent biological 
sample collection (RT-PCR and serology tests) to collect data 
on recent symptoms and vaccination.
Personal biological sampling and testing
1)    Viral testing and whole genome sequencing (WGS) of 
the virus
       Three rounds of RT-PCR (real-time reverse transcrip-
tion – polymerase chain reaction) testing will be offered 
to all participants to identify active SARS-CoV-2 
infections. Participants will self-administer nose and 
throat swabs once a week for three consecutive weeks. 
A pictorial instruction with a link to a YouTube video 
for taking swab samples will be provided. Demon-
stration and supervision for taking swab samples will 
also be provided by on-site study team members. 
Swab samples will be sent directly to the PHE labo-
ratory (Porton Down, UK) for RT-PCR, using Roche 
Cobas SARS-CoV-2 Test16. Home swab tests will 
also be arranged for participants who are absent from 
the workplace due to sickness, self-isolation or other 
reasons. Positive nose and throat swab samples showing 
high levels of viral RNA (i.e. Crossing threshold 
(Ct) value of ≤ 35) will be assessed via WGS to 
detect individual SARS-CoV-2 genotypes, and better 
understand chains of transmission and transmission 
routes.
2)    Antibody testing
       Two rounds of antibody testing, 4-6 weeks apart, will 
be offered to all participants to identify individuals with 
pre-exiting SARS-CoV-2 antibodies and individuals 
who seroconvert during the study. A sample of venous 
blood (5ml) will be taken by a qualified phlebotomist 
at the workplace. The sample will be collected and 
transported the same day to the PHE Porton laboratory 
for analysis, using Roche Elecsys N (nucleocapsid) 
and S (spike protein) antibody tests17. The potential 
antibody test results and their interpretations are 
listed in Table 2.
Environmental assessment, sampling and WGS. A data 
collection framework for environmental assessment has been 
developed for this study18, which maps out information to be 
collected consistently across COVID-19 outbreak sites. For 
each site, contextual information on the physical work environ-
ment is collected including location of spaces, typical occu-
pancy and usage, types of work activities, ventilation and 
heating/cooling systems and measures applied in the workplace 
to mitigate COVID-19 transmission. Environmental sampling 
will be carried out to collect surface samples from work loca-
tions associated with confirmed cases including high-touch 
surfaces (e.g. door handles), infrequently touched surfaces 
(e.g. top of cupboard) and communal areas (e.g. locker rooms, 
canteen) for the quantitative assessment of viral contami-
nation. These samples are collected using wetted swabs 
or sponges from surfaces in the workplace and returned to 
PHE-Porton laboratory for analysis, using a two target (nucle-
ocapside and ORF1ab) RT-PCR assay (Viasure, Zaragoza, 
Spain) to detect and quantify viral RNA. Positive samples 
with Ct values ≤35 will be further analysed via WGS. Viral 
isolation will be undertaken on samples with a Ct value ≤32.
Study setting and study population
The COVID-OUT study will be conducted at workplaces with 
on-going COVID-19 outbreaks identified between December 
2020 and March 2022. According to PHE, an outbreak in a 
non-residential setting requires two or more test-confirmed 
3. Data at the worker population level
   ○   Data relating to the workforce will be collected, including shift patterns, break time, sick pay policy, organised transportation for 
workers travelling to and from work, potential working in fixed groups, and potential onsite accommodation.
   ○   Observational assessments will be conducted on population density, movement of groups of workers and their connectivity, and 
the nature of the work activities.
   ○   Observation assessments will be carried out on control measures implemented (e.g. physical distancing, using barriers, face 
covering, cleaning and other controls), time and location of control measure implementation, general adherence, and potential 
changes of these before and after the outbreak was declared. 
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cases of COVID-19 among individuals associated with the 
setting, with illness onset dates within 14 days, and with 
additional evidence of direct exposure between at least two of 
the test-confirmed cases in that setting or absence of an alter-
native source of infection outside the setting for the initial 
identified cases19. For the purposes of this study, workplaces 
are defined using PHE categories in community surveillance 
of COVID-19. Care homes, hospitals, educational settings, 
prisons, and food outlet/restaurant settings are excluded6. 
Separate studies have been conducted in these sectors20–23.
When recruiting sites, this study will not be limited to specific 
type of workplaces or large enterprises. However, sectors such 
as food or non-food manufacturing plants, warehouses, goods 
distribution centres and large offices, will be prioritised as these 
workplaces are more likely to experience large outbreaks24. 
Identification of outbreaks and the associated population for 
this study are described as follows: 
Identifying COVID-19 outbreaks. The criteria for outbreak 
eligibility for the COVID-OUT study are:
1)    Outbreaks in food processing plants, general manu-
facturing facilities, packaging and distribution centres, 
or large office buildings, with 100 workers or more in 
any of these sites;
2)    An attack rate (i.e. the proportion of the workers 
who become infected25) of 5% or more at the time of 
notification. An outbreak with an attack rate below 
5% but with five confirmed cases or more in a work-
place, will be monitored and included if the out-
break is considered likely to expand further in the next 
1–2 weeks based on evidence gathered by the local 
public health team.
Early alerts of suitable outbreak sites for the study will be 
provided by PHE and HSE through their daily assessment of 
outbreaks/clusters reported in a range of workplace settings. 
Additional mechanisms for getting early notifications include 
reports from regional networks of Directors of Public Health, 
local authority public health departments and large mem-
bership organisations, following the pro-active stakeholder 
engagement of the study team.
Defining the outbreak setting and exposure period. At each 
site, the work area affected by the outbreak will be defined, 
which could include a whole factory with multiple buildings, 
a facility, a single building or an area within a building. A spe-
cific time period of potential exposure for individuals work-
ing within this site will be defined. The exposure period 
starts 2 days before the onset of symptoms (or, for an asymp-
tomatic worker, 2 days before their first positive viral test) in 
the first confirmed case26. The PHE criteria for declaring an 
outbreak over is a period of 28 days after the symptom onset 
date of the last confirmed case19.
Defining the study population. The study includes all workers 
who have been present in the outbreak setting during the poten-
tial exposure period as defined above, including workers 
who are subsequently on sick leave or self-isolating. Workers 
may include, but are not limited to, all employees, contractors, 
agency workers and other personnel who perform work at 
the facility or work setting (e.g. cleaners and security guards 
who may be employed by different companies). This study 
will exclude vulnerable adults with mental incapacity or adults 
in custodial care. In addition, due to tracking constraints, visi-
tors to the outbreak setting will not be eligible for inclusion. 
Information on the visitor population of the outbreak sites will 
be collected, where possible, to assess potential implications 
for transmission.
Recruitment
Soon after an outbreak is notified by PHE or HSE (Figure 1), 
with agreement of the local public health team or HSE 














S-: Spike protein antibody test negative; S+: Spike protein antibody test positive;
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inspectors, a teleconference/video conference will be arranged 
for the field study team to engage with the company/employer 
responsible for the outbreak site.
The study Information Sheet for Employers27 and the Employer 
Consent Form will be provided electronically to the employer 
to seek consent for participation in the study. The Informa-
tion Sheet provides information on the nature of the study 
and what the study will entail. By signing the Consent Form, 
the employer agrees to take part in the study, gives permis-
sion for site access and for onsite data collection, and allows 
employees to complete study associated activities within 
working hours as required.
Upon successful recruitment of the outbreak site, the study 
team will recruit eligible workers to the study. The employer 
will help to identify the work areas affected by the out-
break and all workers who have been present in the outbreak 
area during the at-risk exposure period.
A suitable way to contact and recruit workers to the study will 
be discussed and developed between the employer and the 
study team. The study team will not have contact information 
for workers before they are recruited, and only the employer 
will have this information. Therefore, the cooperation of the 
employer will be essential to recruiting workers on to the study. 
The employer may send an email to invite workers to take 
part in the study by sharing the study Information Sheet for 
Workers28, and links to the online Worker Consent Form 
and the online study questionnaire14. The Information Sheet 
explains to workers the nature of the study, the purpose of the 
study, what their participation entails, and that participation is 
voluntary. Participants will be asked to provide their informed 
consent to a list of activities. Each activity is listed sepa-
rately in the consent form, allowing participants to consent 
to some or all activities. Workers will be given the chance to 
ask questions before consenting. For workers who do not 
have internet access, paper copies of the Information Sheet, 
Consent Form and questionnaire will be available on site. To 
improve participation rates, a member of the study team will be 
available on site to assist with recruitment and answer queries.
Eligible participants will be provided with contact informa-
tion (e.g. phone number or email) of the study coordinator, 
who they can contact directly to consent to the study, to com-
plete the questionnaire over the phone, or if they want further 
information.
In situations where eligible participants do not read or speak 
English, all recruitment materials will be translated into 
their native language, where feasible, in the timeframe of the 
study. Language translation services from PHE and HSE will 
be used for this purpose.
Data collection
Data collection activities are outlined in the study flow chart 
(Figure 1). After giving informed consent, participants will 
complete the study baseline questionnaire online or on paper14.
Participants are invited to have a paired blood test for 
antibodies against SARS-CoV-2, the first in Week 1 and the 
second one in Week 6. Participants will be asked to complete 
a short follow-up questionnaire about any recent symptoms or 
vaccination between the two antibody tests.
Participants will be asked to provide nose and throat swab 
samples to test for current SARS-CoV-2 infection in Week 
1, 2 and 3. Positive swab samples will be sent for WGS to iden-
tify the specific viral strain. Participants will also be asked 
to complete a short follow-up questionnaire about any recent 
symptoms or vaccination since their last swab test.
An environmental assessment visit of the workplace will be 
conducted as soon as employer consent is obtained. Depend-
ing on the progression of each outbreak, a repeat visit for 
further environmental sampling may be required.
Employers will be asked to share with the study team informa-
tion on workforce COVID-19 testing, where available, includ-
ing the numbers and dates of positive cases found among 
workers and the location of their work areas. This information 
will be provided to the study team in a de-identified format.
Sample size
The study will use a case-control design to evaluate risk fac-
tors for SARS-CoV-2 transmission29. Statistical power is cal-
culated for a range of scenarios of combined study population 
size and attack rate to detect an odds ratio (OR) of 2, for a 
binary risk factor with 50% prevalence (Table 3). In order to 
have an adequate statistical power (≥80%) to evaluate com-
mon transmission risk factors for an outbreak, the study would 
need 600 participants and a 10% cumulative attack rate, or 
400 participants and a 20% cumulative attack rate. However, 
if the attack rate in an outbreak is only 5%, the study will need 
a much larger study population size (>1000). Pooled analyses 
Table 3. Statistical power calculations.
Population 
size
Power to detect an odds ratio of 2 








100 0.19 (19%) 0.27 0.39
200 0.28 0.42 0.61
400 0.44 0.66 0.86
600 0.58 0.81 0.95
700 0.63 0.86 0.98
800 0.69 0.90 0.99
900 0.73 0.93 0.99
1,000 0.77 0.95 1.00
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of data collected from multiple outbreak sites will increase 
the sample size and statistical power. In such a scenario, a 
sufficient number of participants could be achieved through 
five to ten individual outbreak investigations, depending 
upon the numbers of workers at each site and the achieved 
participation rates.
Data analysis
Outbreak dynamics. For each outbreak site, a descriptive analy-
sis will be conducted. The number of viral test-confirmed 
COVID-19 cases will be plotted to create an epidemic curve 
(epicurve) to assist rapid assessment of outbreak dynamics. 
Viral test-confirmed cases will also be plotted on a site map 
to visualise the distribution of cases which may guide the 
environmental sampling strategy and help to assess spatial 
dynamics of the outbreak. These findings will be combined 
with the environmental assessment results to support the gen-
eration of hypotheses about the potential factors contributing to 
the outbreak13,30.
Environmental sampling results. Environmental sampling 
and analysis will provide evidence of SARS-CoV-2 contami-
nation in different locations of the work environment. WGS 
of the positive samples collected from workers and from the 
work surfaces may identify clusters of identical SARS-CoV-2 
virus strains which may uncover potential transmission links 
between infected workers, and between workers and the 
work environment. These will help to better understand potential 
transmission routes, their relative importance and the associated 
risk factors31.
Case-control analysis. To assess transmission risk factors, a 
case-control study will be used to compare workers who have 
and have not been infected with SARS-CoV-2 during the out-
break period32. Cases and controls will be identified based on 
the laboratory test results. Workers with a laboratory-confirmed 
SARS-CoV-2 infection will be identified as cases and other 
workers in the same outbreak setting without infection will 
be identified as controls. Here, a case of laboratory-confirmed 
SARS-CoV-2 infection means an individual has either a posi-
tive result in any PCR test or has an antibody test result 
turning from negative to positive that is not due to SARS-CoV-2 
vaccination. Both cases and controls will be from the same 
source population, because all eligible workers from the out-
break site will be invited to take part in the study. All study 
participants will be offered SARS-CoV-2 testing. The base-
line questionnaire will collect possible exposure data from 
workers before tests are conducted to reduce potential recall 
bias. The analysis will use standard modelling strategies33, 
including: 1) Descriptive analyses of the characteristics of 
the workforce under the study, the study participants, and 
comparisons between cases and controls; 2) Univariate analyses 
to consider each of the potential risk factors in turn and 
estimate their odds ratio, adjusted for age and sex; 3) Multiple 
regression analyses to estimate the odds ratio of the potential 
risk factors, adjusting for age, sex, and other possible con-
founders; and 4) Effect modification analyses for variables 
that are of a priori interest34. Pooled analyses across multiple 
outbreak sites will be carried out as described above, with 
adjustments for sites being considered a potential effect 
modifier. Data analyses will be performed using Stata version 
17 and R version 3.6.2 (2019-12-12). 
Ethical approval
The COVID-OUT study has been approved by the NHS North 
East Research Ethics Committee (Reference 20/NE/0282).
Data confidentiality
The participants’ personal data will be protected by the Data 
Protection Act 2018, and the General Data Protection Regula-
tions. Figure 2 summarises the flow of data in the study and the 
role of different study partners in data collection, processing 
and use.
The research findings will be published anonymously, and 
no study participant or outbreak site will be identifiable from 
reports or scientific publications.
Dissemination plans
Key findings will be reported back to the employers and 
other key stakeholders in the form of individual site reports. 
Presentations at scientific meetings and conferences as well 
as peer-reviewed open access publications will be used to 
disseminate the wider findings of the study.
As this study is a component of the National Core Studies, 
data from this study will be anonymised and made available 
through the Trusted Research Environments (TREs) in 
another National Core Study on Data and Connectivity to 
support national COVID-19 research.
Conclusions/discussion
Although there are many COVID-19 outbreaks in workplaces, 
comprehensive epidemiological field studies investigating 
SARS-CoV-2 transmission risk factors and transmission routes 
in workplaces are rarely reported in the scientific literature35. 
Prior to this study, the public health response to outbreaks in 
the UK focused on controlling the individual outbreaks. The 
COVID-OUT study aims to investigate multiple workplaces 
that are experiencing outbreaks to better understand the trans-
mission risk factors and to help prevent and mitigate future 
outbreaks. To achieve these, the study will utilise data already 
collected as part of routine public health outbreak investiga-
tions and collect additional data through a comprehensive 
questionnaire, viral and serologic testing of workers, surface 
sampling, viral genome sequencing, and an environmental 
assessment for research purposes. A multiagency study team 
is formed, bringing together the necessary resource and a group 
of interdisciplinary scientists required to address the research 
questions set out for the COVID-OUT study.
A critical aspect of the success of this approach is getting 
early notifications of workplace outbreaks to facilitate early 
engagement, recruitment and data collection. For example, the 
collection of environmental samples would ideally be as 
close to the peak of the outbreak as practicable. Access to the 
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centralised PHE COVID-19 workplace outbreak surveillance 
data repository should allow for early recruitment, in addition 
to the identification of sectors that are more likely to experience 
outbreaks, such as food manufacturing plants, non-food manu-
facturing plants, warehouses and goods distribution centres24. 
Many of these sectors are part of the national critical infra-
structure and have been operating throughout the pandemic. 
When outbreaks occur in these sectors, affecting a large 
number of workers, employers are under pressure to control 
the outbreaks and to keep the businesses operational, which 
may compromise our study participation rates. However, if 
businesses are willing to take part in the study and the 
worker participation rate is high, the study will identify more 
completely and rapidly SARS-CoV-2 positive cases in the work-
place, and thereby improve isolation rates among infected 
people and break chains of transmission. This will allow for 
a quicker return to a safe working environment, thereby help-
ing to protect and enable business continuity. This study will 
also carry out assessments of the work environment and work-
ing practices that may increase risk of transmission of the 
virus, such as sub-standard hygiene practices or insuf-
ficient ventilation. These findings have the potential to 
improve control measures and prevent further transmission 
at the affected sites, but also to inform policy at national and 
Figure 2. The COVID-OUT study data flow chart.
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international levels, provided specific data can be obtained to 
identify risk factors of SARS-CoV-2 transmission and outbreaks.
The risk of transmission is continuous. A worker or a work-
place setting could be part of a network of transmission events, 
and any workplace could act as a vehicle for transmission. 
Therefore, transmission risk factors associated with work-
places or work activities cannot be considered in isolation. 
This study is designed to comprehensively understand the 
factors that may contribute to workplace outbreaks. The find-
ings of this study will lead to greater understanding of 
how and why outbreaks are occurring, which, in turn, will 
provide insights on how to prevent the spread of the virus 
and make workplaces more COVID-safe. This will help keep 
businesses open while keeping people healthy and safe.
Data availability
Underlying data
No data are associated with this article.
Extended data
Open Science Framework: COVID-19 risk questionnaire for 
workers – COVID-OUT study, https://doi.org/10.17605/OSF.IO/
WR8PH14
Open Science Framework: Information Sheet for Employers – 
COVID-OUT study, https://doi.org/10.17605/OSF.IO/7A28527
Open Science Framework: Information Sheet for Workers – 
COVID-Out study, https://doi.org/10.17605/OSF.IO/GDXCN28
Open Science Framework: Environmental assessment data 
collection framework – COVID-OUT study, https://doi.org/ 
10.17605/OSF.IO/GPBY818
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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